APHON Member Since 2001
Southern California (SCAPHON) Chapter Member Since 2001
Professional Background
Current Position
Director-Patient Care, Pediatric Hematology/Oncology Service Line and Child Life Department
Loma Linda University Children’s Hospital
Loma Linda, CA
Education
- MSN, 2021, Western Governors University, College of Health Professions — Master of Science in Nursing–Leadership and Management
- BSN, 1999, Grand Canyon University, Samaritan College of Nursing — Bachelor of Science in Nursing
Certifications & Credentials
- Fellow of the Association of Pediatric/Hematology Oncology Nurses (FAPHON), 2025
- Certified Pediatric Hematology/Oncology Nurse (CPHON)
- APHON Chemotherapy/Biotherapy Provider
- APHON Chemotherapy/Biotherapy Instructor
Leadership & Service
APHON National Leadership
- APHON Leadership Development Committee — Inaugural Chair, 2023–2024
- APHON Nominating Committee — Chair, 2022–2023; Member, 2020–2023
- APHON Local Chapter Committee — Chair, 2020–2022; Member, 2017–2019
- APHON Counts — Assistant Editor, 2022–2023
- APHON Counts — Section Editor of Local Chapter News, 2020–2022
- APHON Conference Planning Committee — Chair, 2019; Member, 2016–2019
- APHON Rebranding Committee — 2016
- APHON Website Redesign Committee — 2016
APHON Conference & Program Contributions
- APHON Town Hall Moderator — various years, 2016–2025
Local Chapter Leadership
SCAPHON Chapter
- Member, 2001
- Director at Large, 2022-current
- President, 2011-2017
- SCAPHON President Elect, 2010
- Past President, 2017
- Past Conference Planning Chair, 2010
- Conference Planning Chair, 2006-2009
- Fundraising Chair, 2003-2005
Awards & Recognition
Awards
- 2022 — APHON Dr. Patricia Greene Leadership Award
- 2015 — SCAPHON Kathy Ruccione Founders Award for Excellence in Pediatric Hematology/Oncology Nursing
- 2014 — Jessie Rees Foundation Caregiver of the Year
Publications
- 2022 — Local Chapter Prophylaxis: Succession Planning
- 2020 — Self-Care and Resilience: Giving to Ourselves What We Give to Others
- 2020 — MIBG vs. MIBG/vincristine/irinotecan/vorinostat neuroblastoma study
- 2021 — MIBG/vincristine/irinotecan/vorinostat neuroblastoma study
- 2013 — Fenretinide Phase I trial
- 2014 — Fenretinide/ceftriaxone/acetaminophen case report
- 2016 — Buthionine sulfoximine and melphalan study
- 2017 — Neuroblastoma gene expression biomarker study
- 2016 — Alisertib + irinotecan/temozolomide study
- 2015 — MIBG + intensive chemotherapy/stem cell transplantation study
- 2015 — Vorinostat + 131-I-MIBG study
Professional Presentations
- 2012 — Study of Carrier Use and Administration of LXS Powder…
- 2012 — Creativity in the Carrier…
- 2014 — Aurora A kinase inhibitor MLN8237…
- 2014 — BSO and Melphalan…
- 2017–2022 — Presenter at APHON Local Chapter Strategy Sessions each meeting